Moreover, Transwell migration and invasion assays also revealed that the knockdown of IGF2BP2 reversed the increased migration/invasion capacity of VIRMA-overexpressing NPC cells (Fig. 5J). The gene discussed is IGF2BP2; the disease is nasopharyngeal carcinoma.